Basic science highlights: Immune checkpoints in liver tumours and beyond

 Liver tumours
 Basic and translational science

West 1
13 April 2018 11:30 - 12:30

BSH Emerging clinical data attest to the efficacy of triggering tumor-specific immune responses for the treatment of hepatocellular carcinoma, and this therapy also holds promise for the treatment of biliary tract cancers. On the other hand, adaptive immune dysfunction involving mechanisms overlapping with those involved in the inhibition of  tumor-associated immune responses may also participate in the complications of acute liver failure.


General principles of checkpoints inhibition
Pablo Sarobe , Spain
Co-Speaker: Patricia Pochelon
13 April 2018 11:30 - 11:50

Immune mechanisms in the tumour microenvironment of HCC and CCA
Mathias Heikenwälder , Germany
13 April 2018 11:50 - 12:10

Principles and prospects of HCC and CCA immunotherapy
Tim GRETEN , United States
13 April 2018 12:10 - 12:30